About us
We are Imperial College Healthcare
We provide acute and specialist healthcare for over one million people every year.
We particularly serve the local communities in the eight boroughs that form the North West London Integrated Care System. Formed in 2007, we are one of the largest NHS trusts in the country, with more than 15,000 staff.
Our five hospitals in central and west London – Charing Cross, Hammersmith, Queen Charlotte’s & Chelsea, St Mary’s and The Western Eye – have a long track record in research and education, influencing care and treatment nationally and worldwide. We are developing a growing range of integrated and digital care services and offer private healthcare in dedicated facilities on all our sites, including at the Lindo Wing at St Mary’s Hospital.
Building better hospitals
All three of the Trust’s main sites are included in the Government’s New Hospital Programme. This includes a full rebuild of St Mary’s and major refurbishment and some new build at both Charing Cross and Hammersmith hospitals. A new Western Eye Hospital is expected to be incorporated into whichever is the most suitable of the developments.
Latest news See all news
-
Read the full storyConsultation opens on St Mary’s masterplan as estates challenges worsen
Imperial College Healthcare launches a public consultation to inform the first stage of a masterplan for the redevelopment of the St Mary’s Hospital site.
-
Read the full story
Topical HRT protects bone density in women whose periods stop due to anorexia or intense exercise
Researchers at Imperial College London and Imperial College Healthcare NHS Trust have discovered that hormone replacement therapy (HRT) applied to the skin is the best way to protect bone density in women with a condition called functional…
-
Read the full storyShadow Cabinet Ministers meet the Imperial team behind the world-first breath test for pancreatic cancer
Shadow Health Secretary, Stuart Andrew and Shadow Cancer Minister, Caroline Johnson met the Imperial College London scientists working to develop a world-first breath test for pancreatic cancer.
